Side effects: eye and mouth swelling, stomach cramps, fatigue, irritability (diary record)
1 finding from 1 review
no estimate extracted
2 participants
GRADE not reported
Menstrual blood loss Menstruation "more abundant than normal" (questionnaire)
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Side effects: dyspepsia, diarrhoea, headache, fatigue (questionnaire)
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Side effects or other adverse events
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss % occurrence of heavy menstrual bleeding (alkaline hematin method)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Menstrual blood loss % occurrence heavy menstrual bleeding (PBAC score)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Risk of secondary hemorrhage; aspirin · people with traumatic hyphema
Other pharmaceutical agents showed no clear difference in risk of secondary hemorrhage; aspirin compared with placebo or other control interventions (low certainty).
1 finding from 1 review
Intervention not reported
Stroke (fatal and non‐fatal) (a. ticlopidine vs aspirin) (b. clopidogrel vs aspirin & dipyramidole) · patients with type 2 diabetes mellitus
The intervention probably leads to lower stroke (fatal and non‐fatal) (a. ticlopidine vs aspirin) (b.… (moderate certainty).
1 finding from 1 review
MACE · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in MACE compared with aspirin (low certainty).
1 finding from 1 review
Death · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in death compared with aspirin (low certainty).
1 finding from 1 review
All major occlusive vascular events · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intracerebral haemorrhage (ICH) · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in intracerebral haemorrhage (ICH) compared with aspirin (low certainty).
1 finding from 1 review
Functional status ‐ not reported · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ulcer healing · patients with Buerger's disease
(Oral or intravenous) prostanoid probably leads to higher ulcer healing compared with aspirin treatment (moderate certainty).
1 finding from 1 review
Complete relief of rest pain · patients with Buerger's disease
(Oral or intravenous) prostanoid probably leads to higher complete relief of rest pain compared with aspirin treatment (moderate certainty).
1 finding from 1 review
Rate of amputation · patients with Buerger's disease
(Oral or intravenous) prostanoid showed no clear difference in rate of amputation compared with aspirin treatment (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in all‐cause mortality compared with aspirin (moderate certainty).
1 finding from 1 review
Non‐fatal cardiovascular events · patients with heart failure with sinus rhythm
Summary of findings: warfarin showed no clear difference in non‐fatal cardiovascular events (non‐fatal stroke, myocardial… compared with aspirin (moderate certainty).
1 finding from 1 review
Major bleeding · patients with heart failure with sinus rhythm
Summary of findings: warfarin probably leads to higher major bleeding events compared with aspirin (moderate certainty).
1 finding from 1 review
All‐cause mortality · cognitively healthy people in late life
Other NSAIDs showed no clear difference in mortality compared with placebo (moderate certainty).
1 finding from 1 review